Page 139 - CW E-Magazine (23-4-2024)
P. 139

Pharmaceuticals                                                                  Hydrocarbons


 POOLING RESOURCES  IMPORT & STORAGE FACILITY
 Serum Institute of India and Belgium’s Univercells   Petregaz India commissions LPG terminal

 announce personalised cancer treatment collaboration  at Krishnapatnam


 Serum Institute of India (SII),  the   medicines compared to traditional   Petregaz  India, a subsidiary of   large and small and supporting India’s
 Pune based vaccine  major, has joined   approaches.”  Singapore-based LPG shipping and   energy transition away from heavier,
 forces with Univercells, a Belgian bio-  trading company, Petredec Group, has   higher polluting hydrocarbons  to  cleaner
 tech innovator, targeting a dramatic   Critically, Univercells’ technology   inaugurated  its new LPG import  and   burning, affordable and accessible
 increase in accessibility to personalised   also  supports  very-small scale, local   storage terminal at Krishnapatnam,   LPG,” he added.
 cancer care.  This partnership aims to   production. This allows countries, and   Andhra Pradesh.
 bring  cutting edge  treatment options   even hospitals, to provide personalised   Petredec is an integrated LPG com-
 within reach of millions globally.  therapies produced locally. “With SII’s   The newly commissioned facility,   pany that trades, transports and distri-
 global reach, these therapies can reach   with an investment  of Rs. 600-crore,   butes LPG around the world. Petredec
 At present, personalised care  be  a boon for cancer treatment across  patients in Europe, India and the African   enables Petregaz to deliver  “cost-  owns and operates a large and modern
 options such as novel cancer vaccines  the  world, especially  in the  LMICs  continent,” the companies said.  effective and dependable solutions” to  land, optimising logistics and strength-  fl eet  of  35  LPG  carriers,  mainly
 and specialised immunotherapies are  (low-and  middle-income countries),”   LPG marketers as well as residential,  ening  India’s LPG landscape.  This  VLGCs.  Petredec has a growing pre-
 accessible to a few patients only. These  said Dr. Umesh Shaligram,  Executive   Longer term, Univercells  and SII   commercial, industrial and automotive  new  facility  will  also  benefi t  private  sence in the LPG downstream sector
 new therapies  are  developed  using  Director, R&D, SII. “Relapse rates for  believe that they may be able to drama-  customers.  The terminal  is located  marketers and bottlers by improving  with three LPG import terminals in the
 genetic material extracted from  the  many cancers are very high, especially  tically accelerate the  progress  of  new   within  Adani’s Krishnapatnam port,  access to LPG in an area of the country  Indian Ocean.
 patient’s tumours, a process which is  for patients who are diagnosed at a later  medicines.  At  present, the average   25-kms from  Nellore.  The  terminal  historically underdeveloped in terms of
 both time-consuming, and expensive.  stage. To address this, we are develop-  time for a cancer therapy to go from   includes two refrigerated storage tanks –  LPG infrastructure,” Mr. Susheel Raina,   Petregaz is  the Petredec Group’s
 Besides, due to strict  regulatory  limi-  ing  unique  point-of-care cancer treat-  patenting to use by patients is close to   one each for propane and butane, each  CEO, of Petregaz  India,  said in a  downstream subsidiary, specialising in
 tations  on the sequence,  transfer, and  ment using mRNA in combination with  15 years in the UK.  with 30,410-cbm capacity.  release.  LPG  import, storage and large-scale
 manufacturing of  genetic material,  our Recombinant  BCG (VPM1002),”    distribution of LPG. In India, Petregaz
 these treatments are only available in a  he added  “Our target is to reduce that delay to   “Government-run oil companies   “With the launch of the new termi-  Krishnapatnam Pvt. Ltd. is located on the
 handful of countries. This collaboration   just 3 years. We have many barriers to   can utilise our terminal’s  capacity to  nal, we look forward to working with  premises of the  Adani Krishnapatnam
 between SII and Univercells will help   “Our technology can cut months off  overcome, but because we can automate   improve LPG supplies in the hinter-  a host of new customers and partners,  Port Pvt. Ltd.
 in addressing  these challenges, with  the time to create a personalised thera-  the system, we believe we can produce
 a view to capture a proportion of the  peutic without compromising quality.”  personalised therapeutics which still   OUTLOOK
 global cancer care market.  said Mr. José Castillo,  Chief  Techno-  meet the highest standards of quality and
 logy  Offi cer  &  co-founder  of  Univer-  are acceptable to the regulators. There   ‘India accounts for 20% of upcoming regasifi cation
 “We are excited about this collab-  cells. “We’ve completely redesigned  are breakthroughs all the time, but too
 oration  with Univercells  with an aim  the  manufacturing  process  from  fi rst  many are coming too late for the patients   capacity in Asia Pacifi c’
 to strengthen  the  accessibility  of can-  principles and believe that we can save  who need them.  This partnership will
 cer care therapies, which may prove to  up to 90% of costs of producing these  help us change that” said Mr. Castillo.  India, the world’s fourth largest   with a signifi cant 82 percent primarily
       liquefi ed  natural  gas  (LNG)  importer,                          situated within the legacy JKT (Japan,
 US FDA completes inspection of Lupin’s Dabhasa   is  expanding its natural gas  infra-  South Korea, Chinese  Taipei)  group,
       structure by adding 24-mn tonnes per
                                                                          constituting 64 percent and China with
 facility  annum (mtpa) of capacity  accounting                           18 percent. The rest, comprising South
       for around 20 percent of the total
                                                                          and Southeast Asia, contributed to the
 Lupin has announced that the United   “We are pleased to announce the   regasifi cation  capacity  being  added  in   remaining  18 percent.  Among these,
 States Food and Drug Administration   successful completion of the US FDA   Asia Pacifi c.  Japan leads with 210-mtpa, followed
 (U.S. FDA) has completed a GMP   inspection  of our Dabhasa facility.    by South Korea (139-mtpa), China
 inspection of its  API manufacturing   This  accomplishment  underscores our   As per the latest  annual  report of   (100-mtpa) and India (40-mtpa).
 facility located at Dabhasa, Gujarat.   unwavering dedication to maintaining   the  Gas Exporting Countries  Forum
 the  highest  standards of quality  and   (GECF), India will be the world’s larg-  “In 2022, construction  was under-
 The inspection was conducted   compliance in all aspects of our opera-  est growth market for natural gas in the   The GECF  report pointed out that  way for approximately 121-mtpa of
 from  April 8 to  April 12, 2024 and   tions,” said Mr. Nilesh Gupta, Manag-  next decade with China claiming  the  Asia-Pacifi c  boasted  of  around  566-  regasifi cation  capacity  in  Asia  Pacifi c,
 concluded with no observations.  ing Director, Lupin.  top spot till 2030.  mtpa of regasifi cation capacity in 2022,  with China (74-mtpa) and India (24-mtpa)


 138  Chemical Weekly  April 23, 2024  Chemical Weekly  April 23, 2024                                 139


                                      Contents    Index to Advertisers    Index to Products Advertised
   134   135   136   137   138   139   140   141   142   143   144